360° SearchNetwork Hot Spots Trends Time Series

Publication: Ecancer Medicalscience

First reported 9 hours ago - Updated 35 mins ago - 1 reports

Naked mole rats inspire new approach to cancer treatment

Cancer resistance in naked mole rats may be mediated in part by the production of hyaluronan, a natural component found in the extracellular matrix, reports a study published online in Nature.The naked mole rat (Heterocephalus glaber) is known for its ... [Published Ecancer Medicalscience - 9 hours ago]

Entities: Naked Mole Rat, Cancer, extracellular, malignant, Receptor

First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

Early HPV testing could detect sexually transmitted oral cancer

Antibodies to a high-risk type of human papillomavirus (HPV16) could help detect oropharyngeal cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation ... [Published Ecancer Medicalscience - Jun 18 2013]

Entities: Oropharyngeal Cancer, Cancer, Antibody, International Agency for Research on Cancer

First reported Jun 15 2013 - Updated Jun 15 2013 - 1 reports

A new cancer patient database for the UK

The world’s largest database of cancer cases is being set up by Public Health England, the umbrella body established by the UK Government in April 2013 to oversee all English public health provision.This will collect and collate data from all the approximately ... [Published Ecancer Medicalscience - Jun 15 2013]

Entities: Cancer, Database, Tumor, Patient, England

First reported Jun 14 2013 - Updated Jun 15 2013 - 1 reports

FDA Food & Drug Administration

FDA approves the use of denosumab for bone cancer

The U. S. Food and Drug Administration approved denosumab for the treatment of adults and skeletally mature adolescents with giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity.Denosumab’s ... [Published Ecancer Medicalscience - Jun 14 2013]

Entities: Denosumab, objective response, Patient, Tumor, FDA Food & Drug Administration

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

EHA 2013: Targeting the B-cell receptor in aggressive B-cell lymphomas

The last 30 years have seen a plethora of treatments for diffuse large B-cell lymphoma (DLBCL) but few advances have been made.Recent studies identified B-cell receptor signaling as critical for many B-cell lymphomas including the most common type, called ... [Published Ecancer Medicalscience - Jun 14 2013]

Entities: Ibrutinib, Receptor, lymphoma

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

EHA 2013: Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

LATEST : Register now for the 2013 WIN Symposium, ecancer members receive a 10% discount News: FDA approves the use of denosumab for bone cancer News: EHA 2013: Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for chronic lymphocytic ... [Published Ecancer Medicalscience - Jun 14 2013]

Entities: Multiple Myeloma, Monoclonal Antibodies, Pomalidomide, chlorambucil, Denosumab

First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Research: Prognostic factors in early-stage ovarian cancer

: 10.3332/ecancer.2013.325Germana Tognon, Mario Carnazza, Monica Ragnoli, Stefano Calza, Federico Ferrari, Angela Gambino, Valentina Zizioli, Sara Notaro, Benedetta Sostegni and Enrico SartoriThe purpose of this study was to identify the main prognostic ... [Published Ecancer Medicalscience - Jun 14 2013]

Entities: Ovarian Cancer, Cytology, Adjuvant Chemotherapy, Adhesive

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

400,000 UK cancer patients survive decade after diagnosis

There are currently around 400,000 people in England who have survived cancer between ten and 20 years after diagnosis, according to new research by Macmillan Cancer Support and the National Cancer Intelligence Network (NCIN).This study looks at the number ... [Published Ecancer Medicalscience - Jun 12 2013]

Entities: Cancer, Macmillan Cancer Support, United Kingdom, Patient

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

European Cancer Patient Coalition elects new president

The European Cancer Patient Coalition (ECPC) Annual General Assembly, elected Francesco De Lorenzo as new President in charge for the next 3 years.For the first time, an Italian at the helm of the European Coalition of Cancer Patients.Prof. Francesco ... [Published Ecancer Medicalscience - Jun 12 2013]

Entities: Cancer, Patient, Coalition

First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports

Case Report: Literature meta-analysis of zosteriform cutaneous metastases from melanoma and a clinico-histopathological report from India

: 10.3332/ecancer.2013.324Savita Chaudhary, Cherry Bansal and Ayanat HusainCutaneous metastases in patients with malignant tumours are an important clue to tumour progression or even the first manifestation of malignancy. Among the various topographic ... [Published Ecancer Medicalscience - Jun 12 2013]

Entities: Skin Cancer, Metastases, Metastasis, case report

First reported Jun 02 2013 - Updated Jun 03 2013 - 2 reports

ASCO 2013: Bevacizumab extends survival for relapsed and advanced cervical cancer

A randomised phase III study assessing two different chemotherapy regimens with or without bevacizumab finds that adding bevacizumab prolongs overall survival by an average of four months compared to chemotherapy alone.The study represents the first time ... [Published Ecancer Medicalscience - Jun 02 2013]

Entities: bevacizumab, CERVICAL CANCER, Chemotherapy

First reported May 30 2013 - Updated May 30 2013 - 2 reports

FDA approves use of trametinib for treatment of unresectable or metastatic melanoma

The U. S. Food and Drug Administration approved trametinib, for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutation as detected by an FDA-approved test.Concurrent with this approval, FDA approved the THxID ... [Published Ecancer Medicalscience - May 30 2013]

Entities: trametinib, Patient, Skin Cancer, Metastatic

Quotes

"It's great news that this national database has been set up. It means we have all the UK's cancer information in one place making us well equipped to provide the highest quality care for every cancer patient… and to further cancer research”, she said."

A new cancer patient database for the UK [Published Ecancer Medicalscience - Jun 15 2013]

"Protecting the rights of people affected by cancer must be a priority of all governments. And in the next three years we will work for developing a common policy at the European level, drawing on the experience gained in Italy with FAVO" said Prof. De Lorenzo

European Cancer Patient Coalition elects new president [Published Ecancer Medicalscience - Jun 12 2013]

"Because of the progress in healthcare - ironically largely for conditions other than cancer - in only seven years time nearly half the population will get cancer in their lifetime. This poses a herculean challenge for the NHS and for society."

Half of UK will get cancer in their lifetime by 2020 [Published Ecancer Medicalscience - Jun 07 2013]

"This landmark trial confirms recent findings of the ATLAS trial showing that extending therapy with tamoxifen to 10 years significantly lowers breast cancer recurrences and mortality. These results are therefore practice changing for premenopausal women with hormone receptor positive breast cancer and especially relevant for women who are at high risk of recurrence" said Sylvia Adams, MD, ASCO spokesperson and breast cancer expert

ASCO 2013: Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death [Published Ecancer Medicalscience - Jun 02 2013]

More Content

sort by: Date \| Relevance
Naked mole rats inspire new approach to cancer ... [Published Ecancer Medicalscience - 9 hours ago]
Early HPV testing could detect sexually transmi... [Published Ecancer Medicalscience - Jun 18 2013]
A new cancer patient database for the UK [Published Ecancer Medicalscience - Jun 15 2013]
FDA approves the use of denosumab for bone cancer [Published Ecancer Medicalscience - Jun 14 2013]
EHA 2013: Targeting the B-cell receptor in aggr... [Published Ecancer Medicalscience - Jun 14 2013]
EHA 2013: Daratumumab, a CD38 monoclonal antibo... [Published Ecancer Medicalscience - Jun 14 2013]
Research: Prognostic factors in early-stage ova... [Published Ecancer Medicalscience - Jun 14 2013]
European Cancer Patient Coalition elects new pr... [Published Ecancer Medicalscience - Jun 12 2013]
400,000 UK cancer patients survive decade after... [Published Ecancer Medicalscience - Jun 12 2013]
Case Report: Literature meta-analysis of zoster... [Published Ecancer Medicalscience - Jun 12 2013]
Study reveals cancer survivors and partners at ... [Published Ecancer Medicalscience - Jun 10 2013]
Half of UK will get cancer in their lifetime by... [Published Ecancer Medicalscience - Jun 07 2013]
New UK lung cancer survey goes 'live' [Published Ecancer Medicalscience - Jun 06 2013]
ASCO 2013: Novel drug that inhibits Hsp90 effec... [Published Ecancer Medicalscience - Jun 03 2013]
ASCO 2013: Surveys reveal shortages of common c... [Published Ecancer Medicalscience - Jun 03 2013]
ASCO 2013: Two commonly used paclitaxel chemoth... [Published Ecancer Medicalscience - Jun 03 2013]
ASCO 2013: Ten years of tamoxifen superior to f... [Published Ecancer Medicalscience - Jun 02 2013]
ASCO 2013: Bevacizumab extends survival for rel... [Published Ecancer Medicalscience - Jun 02 2013]
ASCO 2013: Sorafenib stalls growth of treatment... [Published Ecancer Medicalscience - Jun 02 2013]
ASCO 2013: No survival benefit to adding bevaci... [Published Ecancer Medicalscience - Jun 02 2013]
ASCO 2013: Indian study finds biennial cervical... [Published Ecancer Medicalscience - Jun 02 2013]
ASCO completes electronic data sharing standard... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: Maintenance therapy with the multi-t... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: New MEK inhibitor selumetinib is the... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: Spouses of patients with HPV-positiv... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: Adding GM-CSF to ipilimumab signific... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: Anti-PD-1 drug nivolumab shows high ... [Published Ecancer Medicalscience - Jun 01 2013]
ASCO 2013: Phase III study finds cetuximab supe... [Published Ecancer Medicalscience - Jun 01 2013]
Cancer Research UK launches trial for potential... [Published Ecancer Medicalscience - May 31 2013]
FDA approves use of trametinib for treatment of... [Published Ecancer Medicalscience - May 30 2013]